A randomized safety and pharmacokinetic trial of daily tenofovir 1% gel in term and near-term pregnancy

INTRODUCTION: Vaginal tenofovir (TFV) 1% gel may reduce incident HIV-1 and herpes simplex virus 2 infection. Pregnancy may increase risk of HIV acquisition, and incident HIV in pregnancy potentiates perinatal HIV transmission. Our objective was to investigate the safety and pharmacokinetics of seven...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Int AIDS Soc
Main Authors: Beigi, Richard H, Noguchi, Lisa M, Montgomery, Elizabeth, Biggio, Joseph, Hendrix, Craig W, Marzinke, Mark A, Dai, James Y, Pan, Jason, Na Ayudhya, Ratiya Kunjara, Schwartz, Jill L, Isaacs, Karen, Piper, Jeanna M, Watts, D Heather
格式: Artigo
語言:Inglês
出版: International AIDS Society 2016
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034095/
https://ncbi.nlm.nih.gov/pubmed/27658440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.19.1.20990
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍